Articoli con mandati relativi all'accesso pubblico - J Dedrick Jordan, MD, PhDUlteriori informazioni
Non disponibile pubblicamente: 1
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
AM Lincoff, R Mehran, TJ Povsic, SL Zelenkofske, Z Huang, ...
The Lancet 387 (10016), 349-356, 2016
Mandati: US National Institutes of Health
Disponibili pubblicamente: 38
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
RR Holman, MA Bethel, RJ Mentz, VP Thompson, Y Lokhnygina, JB Buse, ...
New England Journal of Medicine 377 (13), 1228-1239, 2017
Mandati: US National Institutes of Health
Sotagliflozin in patients with diabetes and chronic kidney disease
DL Bhatt, M Szarek, B Pitt, CP Cannon, LA Leiter, DK McGuire, JB Lewis, ...
New England Journal of Medicine 384 (2), 129-139, 2021
Mandati: National Institute for Health Research, UK
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: the ODYSSEY ALTERNATIVE randomized trial
PM Moriarty, PD Thompson, CP Cannon, JR Guyton, J Bergeron, FJ Zieve, ...
Journal of clinical lipidology 9 (6), 758-769, 2015
Mandati: US National Institutes of Health
Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study
JJ Bazarian, P Biberthaler, RD Welch, LM Lewis, P Barzo, V Bogner-Flatz, ...
The Lancet Neurology 17 (9), 782-789, 2018
Mandati: US Department of Defense
Extended thromboprophylaxis with betrixaban in acutely ill medical patients
AT Cohen, RA Harrington, SZ Goldhaber, RD Hull, BL Wiens, A Gold, ...
New England Journal of Medicine 375 (6), 534-544, 2016
Mandati: National Institute for Health Research, UK
Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial
EC Haley Jr, JLP Thompson, JC Grotta, PD Lyden, TG Hemmen, ...
Stroke 41 (4), 707-711, 2010
Mandati: US National Institutes of Health
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The lancet Diabetes & endocrinology 7 (8), 618-628, 2019
Mandati: US National Institutes of Health, National Institute for Health Research, UK
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial
JW Jukema, M Szarek, LE Zijlstra, HA de Silva, DL Bhatt, VA Bittner, ...
Journal of the American College of Cardiology 74 (9), 1167-1176, 2019
Mandati: Dutch Heart Foundation
Lipoprotein (a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
M Szarek, VA Bittner, P Aylward, M Baccara-Dinet, DL Bhatt, R Diaz, ...
European heart journal 41 (44), 4245-4255, 2020
Mandati: US National Institutes of Health, American Heart Association, National …
Effect of alirocumab on mortality after acute coronary syndromes: an analysis of the ODYSSEY OUTCOMES randomized clinical trial
PG Steg, M Szarek, DL Bhatt, VA Bittner, MF Bregeault, AJ Dalby, R Diaz, ...
Circulation 140 (2), 103-112, 2019
Mandati: National Institute of Health and Medical Research, France
Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial
SD Pokorney, GM Chertow, HR Al-Khalidi, D Gallup, P Dignacco, ...
Circulation 146 (23), 1735-1745, 2022
Mandati: US National Institutes of Health
Cardiovascular safety of degarelix versus leuprolide in patients with prostate cancer: the primary results of the PRONOUNCE randomized trial
RD Lopes, CS Higano, SF Slovin, AJ Nelson, R Bigelow, PS Sørensen, ...
Circulation 144 (16), 1295-1307, 2021
Mandati: US National Institutes of Health
Lipoprotein (a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol
GG Schwartz, M Szarek, VA Bittner, R Diaz, SG Goodman, JW Jukema, ...
Journal of the American College of Cardiology 78 (5), 421-433, 2021
Mandati: US National Institutes of Health, Heart and Stroke Foundation of Canada …
Effect of ejection fraction on clinical outcomes in patients treated with omecamtiv mecarbil in GALACTIC-HF
JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ...
Journal of the American College of Cardiology 78 (2), 97-108, 2021
Mandati: US National Institutes of Health, German Research Foundation
Microvascular and cardiovascular outcomes according to renal function in patients treated with once-weekly exenatide: insights from the EXSCEL trial
MA Bethel, RJ Mentz, P Merrill, JB Buse, JC Chan, SG Goodman, N Iqbal, ...
Diabetes Care 43 (2), 446-452, 2020
Mandati: US National Institutes of Health, National Institute for Health Research, UK
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis
PR Sinnaeve, GG Schwartz, DM Wojdyla, M Alings, DL Bhatt, VA Bittner, ...
European heart journal 41 (24), 2248-2258, 2020
Mandati: Patient-Centered Outcomes Research Institute, Dutch Heart Foundation
Cardiovascular and limb outcomes in patients with diabetes and peripheral artery disease: the EUCLID trial
CC Low Wang, JI Blomster, G Heizer, JS Berger, I Baumgartner, ...
Journal of the American College of Cardiology 72 (25), 3274-3284, 2018
Mandati: US National Institutes of Health, American Heart Association, Doris Duke …
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
HD White, PG Steg, M Szarek, DL Bhatt, VA Bittner, R Diaz, JM Edelberg, ...
European heart journal 40 (33), 2801-2809, 2019
Mandati: Dutch Heart Foundation
Cost-effectiveness of alirocumab in patients with acute coronary syndromes: the ODYSSEY OUTCOMES trial
DL Bhatt, AH Briggs, SD Reed, L Annemans, M Szarek, VA Bittner, R Diaz, ...
Journal of the American College of Cardiology 75 (18), 2297-2308, 2020
Mandati: US National Institutes of Health, American Heart Association, Patient …
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software